Last reviewed · How we verify

A UKLG Randomised Trial of Initial Chemotherapy for Advanced Stage Hodgkins Disease

NCT00003421 Phase 3 COMPLETED

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which chemotherapy regimen is more effective for advanced Hodgkin's disease. PURPOSE: Randomized phase III trial to compare different combination chemotherapy regimens in treating patients with advanced Hodgkin's disease.

Details

Lead sponsorMedical Research Council
PhasePhase 3
StatusCOMPLETED
Enrolment800
Start date1998-06
Completion2005-11

Conditions

Interventions

Countries

United Kingdom